Fighting leukemia. Survival rates have tripled thanks to new, more effective treatments.
D000208:Acute Disease; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D002908:Chronic Disease; D017338:Cladribine / Q000627:therapeutic use; D006801:Humans; D000068877:Imatinib Mesylate; D007938:Leukemia / Q000209:etiology / Q000401:mortality / Q000628:therapy; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D015996:Survival Rate
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D017338:Cladribine; D000068877:Imatinib Mesylate